These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8621196

  • 1. The fibrinolytic system is not impaired in older men with hypertension.
    DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF.
    Hypertension; 1996 May; 27(5):1053-8. PubMed ID: 8621196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Enhanced levels of tissue-type plasminogen activator in borderline hypertension.
    Wall U, Jern C, Bergbrant A, Jern S.
    Hypertension; 1995 Nov; 26(5):796-800. PubMed ID: 7591020
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Beta blockers, Lp(a), hypertension, and reduced basal fibrinolytic activity.
    Glueck CJ, Glueck HI, Hamer T, Speirs J, Tracy T, Stroop D.
    Am J Med Sci; 1994 May; 307(5):317-24. PubMed ID: 7909648
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinolytic system in normotensive subjects and hypertensive patients.
    Armas-Hernández MJ, Hernández-Hernández R, Armas-Padilla MC, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero-Pajuelo J, Israili ZH, Valasco M.
    Am J Ther; 2007 May; 14(2):177-82. PubMed ID: 17414587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance.
    Ma J, Albornoz F, Yu C, Byrne DW, Vaughan DE, Brown NJ.
    Hypertension; 2005 Aug; 46(2):313-20. PubMed ID: 15998706
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.